Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Landman

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|January 28, 2005
Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New YorkSimona Bratu, David Landman, Maqsood Alam, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2017
In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniaeSarath Nath, Farzad Moussavi, Daniel Abraham, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2018
Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emergesAlejandro Iregui, Karen Ha, Katharine Meleney, et al.
Emerging Infectious Diseases|May 25, 2002
Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstepJohn Quale, David Landman, Jayashree Ravishankar, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 22, 2022
<i>In Vitro</i> and <i>In Vivo</i> Activity of Amoxicillin-Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>Aanchal Gupta, Saquib Malik, Monica Kaminski, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2008
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York CitySimona Bratu, David Landman, Don Antonio Martin, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York CityMarie Abdallah, Olawole Olafisoye, Christopher Cortes, et al.
Annals of Clinical Microbiology and Antimicrobials|December 2, 2006
A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York CitySimona Bratu, David Landman, Jyoti Gupta, et al.
International Journal of Antimicrobial Agents|May 7, 2014
In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolatesDavid Landman, Manisha Singh, Badiaa El-Imad, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2010
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York CityDavid Landman, Elizabeth Babu, Neha Shah, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|January 28, 2005
Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New YorkSimona Bratu, David Landman, Maqsood Alam, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2017
In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniaeSarath Nath, Farzad Moussavi, Daniel Abraham, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2018
Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emergesAlejandro Iregui, Karen Ha, Katharine Meleney, et al.
Emerging Infectious Diseases|May 25, 2002
Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstepJohn Quale, David Landman, Jayashree Ravishankar, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 22, 2022
<i>In Vitro</i> and <i>In Vivo</i> Activity of Amoxicillin-Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>Aanchal Gupta, Saquib Malik, Monica Kaminski, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2008
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York CitySimona Bratu, David Landman, Don Antonio Martin, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York CityMarie Abdallah, Olawole Olafisoye, Christopher Cortes, et al.
Annals of Clinical Microbiology and Antimicrobials|December 2, 2006
A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York CitySimona Bratu, David Landman, Jyoti Gupta, et al.
International Journal of Antimicrobial Agents|May 7, 2014
In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolatesDavid Landman, Manisha Singh, Badiaa El-Imad, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2010
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York CityDavid Landman, Elizabeth Babu, Neha Shah, et al.
Pageof 6